Trade Moderna Inc ^MRNA

Moderna (NASDAQ:MRNA) Trading Up 12.3% - Still a Buy?

Health Care Up on Drug Breakthrough Hopes - Health Care Roundup | Morningstar

Moderna will reveal the data for its mRNA cancer vaccine next month. Here's why it matters. | Morningstar

Moderna (NASDAQ:MRNA) Sets New 12-Month High - Here's Why

Moderna Surges 9% as Phase 3 Melanoma Data Wins Presidential Symposium Slot; Merck and BioNTech Edge Higher

Moderna Announces Late-Breaking Data to be Presented at ESMO Congress 2026 | Morningstar

Biotech Stocks To Watch Now - September 21st - Daily Political

Moderna's Bob Langer and Yann LeCun join Cellular Intelligence advisory board to advance AI in medicine

Moderna, Inc. $MRNA Shares Acquired by Baird Financial Group Inc.

Moderna (NASDAQ:MRNA) Trading Up 8.5% - Here's What Happened

Moderna (MRNA) Dropped, So What Is Behind The Latest Attention?

Bank of America Corp DE Invests $98.72 Million in Moderna, Inc. $MRNA

Moderna (NASDAQ:MRNA) Shares Down 2.6% - What's Next?

Neuphoria Therapeutics (NASDAQ:NEUP) vs. Moderna (NASDAQ:MRNA) Financial Comparison

Promising Healthcare Stocks To Follow Today - September 18th - Stock Observer

Best Healthcare Stocks To Research - September 17th - Markets Daily

Moderna (NASDAQ:MRNA) Trading 8.5% Higher - Time to Buy? - Daily Political

Biotech Stocks To Keep An Eye On - September 17th - Stock Observer

TEM: Cancer Vaccine Sequencing Partnerships Will Drive Future Upside

Moderna Inc Stock Live Price, Chart, Analysis, News & Forecast - Buy, Sell & Trade US Equities Today

Moderna (NASDAQ:MRNA) Shares Up 1.3% - Should You Buy?

Stephen Hoge Sells 40,294 Shares of Moderna (NASDAQ:MRNA) Stock

Insider Selling: Moderna (NASDAQ:MRNA) President Sells $5,883,845.67 in Stock - Daily Political

Best Healthcare Stocks To Follow Today - September 16th - Stock Observer

Moderna (NASDAQ:MRNA) Shares Down 2% Following Insider Selling - Zolmax

Cboe data shows mixed options sentiment in Moderna with shares down 2.14%

Moderna (MRNA) Ascends While Market Falls: Some Facts to Note

Moderna (NASDAQ:MRNA) CFO Sells $4,685,093.64 in Stock

AI in healthcare advances melanoma treatment and drug repurposing | Fox News

Recent Analysts' Ratings Updates for Moderna (MRNA) - Stock Observer

Moderna's COVID Vaccine Was a Historic Success. Could Its Cancer Vaccine Be Even Bigger? - AOL

Congresswoman Bets on Elon Musk, Warren Buffett: Here's the Latest Stock Transactions

Moderna's Cancer Vaccine Win Fuels Broad Push Across Tumor Types

AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033 | Morningstar

Rep. Maria Elvira Salazar Buys Shares of Moderna, Inc. (NASDAQ:MRNA) - Stock Observer

California State Teachers Retirement System Buys 27,274,128 Shares of Moderna, Inc. $MRNA

Moderna (NASDAQ:MRNA) Shares Up 6.7% - Should You Buy?

Moderna Rallies 8% on 2026 Melt-Up Momentum Even While BioNTech and Merck Stay Flat

New FDA Drug Approvals - August 2026

AI Discovers Revolutionary Lung Drug That Makes People 3 Years "Younger" After Just 4 Weeks of Use

Amundi Reduces Stock Holdings in Moderna, Inc. $MRNA

Healthcare Stocks To Add to Your Watchlist - September 10th - Stock Observer

Influenza A Market Insight, Epidemiology, and Market Forecast - 2036 Now Available - See Why a 70% Vaccine Failure Rate Is Fueling the Race for Next-Gen Flu Therapies

Murphy Pohlad Asset Management LLC Makes New Investment in Moderna, Inc. $MRNA - Markets Daily

West Virginia meat processor struggling under weight of tariffs & high beef prices

Cancer vaccines could transform treatment and prevention

Nykredit A S Invests $913,000 in Moderna, Inc. $MRNA

AI helps create drug that may slow down ageing by 6 years in few weeks

Swapped Lives: The 15-Year Fork in the Road Between Moderna and BioNTech

The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI

Promising Biotech Stocks To Consider - September 7th - Zolmax

The Second Act of Biotech

Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva

Moderna, Inc. (NASDAQ:MRNA) Receives Average Recommendation of "Hold" from Brokerages - Markets Daily

How Is Moderna's Stock Performance Compared to Other Healthcare Stocks

NEOS Investment Management LLC Purchases 5,811 Shares of Moderna, Inc. $MRNA - Daily Political

MRNA, PHVS and ABBV Stocks: 3 Healthcare Plays for the Next Week, Year and Decade

AlphaGrep UK Ltd Invests $568,000 in Moderna, Inc. $MRNA

Moderna (NASDAQ:MRNA) Cut to Sell at Rothschild & Co Redburn

Healthcare Stocks To Consider - September 5th - Stock Observer

Moderna, Inc. $MRNA is Step Capital Management Pte. Ltd.'s 2nd Largest Position - Markets Daily

Step Capital Management Pte. Ltd. Has $48.67 Million Stake in Moderna, Inc. $MRNA

22,477 Shares in Moderna, Inc. $MRNA Acquired by AXQ Capital LP

Moderna (MRNA) Stock Trades Above Fair Value After Its 479% Run

Proficio Capital Partners LLC Takes $298,000 Position in Moderna, Inc. $MRNA - Stock Observer

What Does Moderna (MRNA) Bird Flu Phase 3 Trial Mean For Its Growth?

Can anything bring sky-high airline prices down? The Points Guy weighs in

Moderna (MRNA) Stock Looks Expensive On Sales After A Very Large Run

Wall Street Has Cooled on Moderna After Its Stock Jumped Over 5X. But Does the mRNA Leader Have More Room to Run?

Moderna's updated COVID-19 vaccine will target Omicron XFG variant

GSK's mRNA flu vaccine data closely tracks Moderna's, Deutsche Bank says

Healthcare Overtakes AI to Become Hedge Funds' Largest Holding

Why Moderna (MRNA) Stock Is Down Today

RGEN: Cancer Vaccine Exposure And Bioprocess Deals Will Shape Outlook

BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now?

Moderna (MRNA) Price Forecast: Bullish Pennant Points Toward Higher Targets

Moderna (NASDAQ:MRNA) Insider Sells $485,766.45 in Stock

Moderna (MRNA) Started A Phase 3 Bird Flu Vaccine Trial

Best Healthcare Stocks To Research - September 3rd

Does Moderna's mRNA Flu Shot Face a New Challenge From GSK?

3 Stocks Whose Competitive Walls Tower Over Nvidia's

This Fund Bought Moderna Before It Nearly Tripled. See Its 2 New Stock Picks

Moderna (NASDAQ:MRNA) Shares Gap Down on Analyst Downgrade

Rothschild & Co Redburn Downgrades Moderna (NASDAQ:MRNA) to Sell

Here Are Thursday's Top Wall Street Analyst Research Calls: Broadcom, Deere & Company, Dell Technologies, Devon Energy, Moderna, Permian Resources, PG&E, Thermo Fisher, Viper Energy, and More

Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Avalanche Price Prediction 2026–2030: Can Institutional Tokenization Push AVAX Back Above $10?

Week Ahead: PBoC and SNB rate decisions

Gold Price Forecast 2026, 2027 and 2030: Can Gold Hold $4,200 After the Fed’s First Rate Hike Since 2023?

Is SpaceX a Good Stock to Buy in 2026?

Best Gold Stock to Buy Now: 6 Gold Stocks to Watch in 2026

Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?

Gold Price Trend 2024-2026: From $2,000 to Record Highs, What Comes Next?

Upcoming IPOs 2026: The Biggest Companies to Watch and Major Listings So Far

Moderna Stock Soars 177% as Cancer Vaccine Delivers a Landmark Phase 3 Win

SpaceX Nasdaq-100 Weight More Than Doubles, Setting Up Billions in Passive Buying

Gold Price Today: Gold Edges Lower Near $4,372 as Fed Rate Outlook Keeps Yields Elevated

Bitcoin Surges Toward $84,000 on SEC Relief and ETF Inflows

Gold Price Forecast This Week: Can XAU/USD Hold $4,350 as Fed Speakers Turn Hawkish?

SoftBank Raises Over $11 Billion for OpenAI: What the Bond Deal Means for the Stock

US PMI Preview: Will Strong Business Activity Push the 10-Year Treasury Yield Back Above 5%?

Nvidia CEO Jensen Huang Rejects AI Slowdown Calls as Industry Divide Deepens

Trump-Xi Meeting Preview: Can an AI Deal and Tariff Relief Lift Global Markets?